Sprycel 50 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9KQ3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,561
Award facts
- Contract value 100% obligated
- $18,560.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,560.63 to AmerisourceBergen Drug Corp for the supply of Sprycel 50 mg tablets (60-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the corporate headquarters for AmerisourceBergen Drug Corp. This delivery order is issued under the parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2031), which functions as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs worldwide.
AmerisourceBergen's role as a critical pharmaceutical distributor positions it to fulfill federal medical procurement needs across multiple therapeutic domains for military and veteran healthcare systems. The company's contract awards demonstrate extensive experience delivering oncology treatments, specialty medications, and other essential pharmaceutical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This delivery order for Sprycel (dasatinib), a targeted cancer therapy, exemplifies the company's capability to efficiently supply specialized pharmaceutical products required by federal medical institutions under a firm fixed-price structure.
Quick answers
Who was awarded contract SPE2DR26F9KQ3?
SPE2DR26F9KQ3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F9KQ3 worth?
The government has obligated $18,561 on SPE2DR26F9KQ3.
Is contract SPE2DR26F9KQ3 an order under another contract?
Yes. SPE2DR26F9KQ3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KQ3 competed?
The extent of competition for SPE2DR26F9KQ3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award